Synterica makes oral therapeutics for treatment of enteric disease with a goal of promoting gastrointestinal health. Our products directly target pathogenic bacteria and their toxins in the gut without harming beneficial bacteria. While antibiotics have saved many lives, we live in an era when bacterial resistance to antibiotics has become a problem. In addition to the problems of resistance, antibiotics can disrupt the healthy balance of gut microflora allowing pathogenic bacteria to flourish and directly contribute to disease. These problems drive the need for new and innovative therapeutics. Synterica is developing innovative therapeutics that directly bind to and eliminate selected pathogenic bacteria and their toxins in the gut. We do this by combining specific targeting and neutralizing agents with natural packaging material made from living ingestible organisms that also serve as the means for large-scale production. Our first target is an oral therapeutic to neutralize the toxins secreted by Clostridium difficile. The two toxins are responsible for the devastating effects of the infection and neutralizing them is expected to reduce pathogenesis of the disease.
View Top Employees from Synterica, Inc.Website | http://www.synterica.com |
Revenue | $608000 |
Employees | 2 (0 on RocketReach) |
Founded | 2014 |
Address | 1448 S Rolling Rd, Ste 21, Halethorpe, Maryland 21227, US |
Phone | (443) 297-9668 |
Industry | Business Services, Biotechnology Research |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Synterica, Inc. employee's phone or email?
The Synterica, Inc. annual revenue was $608000 in 2024.
Synterica, Inc. is based in Halethorpe, Maryland.
The NAICS codes for Synterica, Inc. are [54171, 541713, 5417, 54, 541].
The SIC codes for Synterica, Inc. are [87, 873].